David (Wei) Liu

北京星亢原生物科技有限公司（neoX Biotech）是一家将人工智能（AI）与生物物理相结合，进行药物研发的生物高科技公司。星亢原专注大分子和多特异性分子药物研发，尤其是在肿瘤免疫治疗领域。 针对治疗药物的早期发现，星亢原通过表征蛋白质-蛋白质相互作用（PPI）开发了一个强大的研发平台。星亢原已经与国内外生物医药公司建立合作，布局药物研发管线。 星亢原由美国麻省理工学院和加州理工学院毕业的两位博士创立，核心研发团队来自北京大学、美国莱斯大学、中国科学院、德国亥姆霍兹感染研究中心、默沙东（MSD）等生物医药领域研究机构和跨国药企，团队成员曾在《自然》《科学》《细胞》等国际顶级期刊发表有重大影响力的学术文章，并被媒体报道。公司已经获得了包括红杉资本、五源资本（原晨兴资本）、元璟资本、真格基金、云九资本、祥峰投资、BAI资本在内的顶尖风险投资基金投资。

As the leading AI-based microbiome drug development company in China, Xbiome Co., Ltd. is dedicated to gut microbiome using AI techniques, and committed to the gut health of human being with medical treatments and precise and personalized management. The gut is the largest microbial ecosystem in the human body. It hosts about 100 trillion microbes – 500 – 1000 unique species, and contains 150-fold more genes than the human genome, which influence the human health systematically. Studies show that more than 50 human diseases are associated with dysbiosis of gut microbiota. Unlike the traditional paradigm of drug discovery, Xbiomes approach innovatively combines microbial technologies, artificial intelligence, bioinformatics analysis and gut microbiome technologies into a unique drug development platform, which substantially speeds up and improves the success rate of new drug development.

TuSimple is a global autonomous driving technology company headquartered in San Diego, California, with operations in the United States and Asia. Founded in 2015, TuSimple is developing commercial-ready, SAE Level 2+ through Level 4 autonomous driving solutions for long-haul heavy-duty trucks. TuSimple aims to transform the $4 trillion global truck freight industry through the companys leading AI technology, which makes it possible for trucks to drive safely autonomously, operate nearly continuously, and reduce fuel consumption by 10%+ relative to manually driven trucks. Global achievements include the worlds first fully autonomous, driver-out semi-truck run on open public roads, and development of the worlds first Autonomous Freight Network (AFN). We’re looking for creative and entrepreneurial individuals to join us. Please view positions at https://www.tusimple.com/careers/

We are a passionate team of veteran game developers focused on developing amazing games. We build triple A quality experiences and the backend tech that drives them.

THETA.tv (fka SLIVER.tv) is the next-generation esports entertainment platform powered by blockchain technology. Based in San Jose, CA, the company is backed by top-tier Silicon Valley VCs and Hollywood media investors and is on a mission to transform the interactive esports entertainment industry.

Channel Factory is a global technology and data platform that maximizes both performance efficiency and contextual suitability, delivering contextual performance for advertisers on YouTube. Channel Factory’s technology platform, ViewIQ, analyzes all YouTube channels and videos to ensure ads run on brand suitable and contextually relevant content. Channel Factory maximizes performance for advertisers on YouTube through managed service or self-service dynamic whitelists & blacklists, easily implemented through DV360 or Google Ads. Our platform is built to meet the needs of advertisers, offering standard IAB category lists or highly customized content lists in 36+ languages. Why Contextual Suitability? In our reviews of campaigns run outside of Channel Factory, we see on average 28% of an advertiser's campaign run against unsuitable videos, such as children’s content or against the wrong language. Leveraging historical performance data is a key differentiator for Channel Factory. We do not just ‘set it and forget it’ when it comes to contextual suitability. We incorporate active and historical campaign data into our ViewIQ platform and constantly optimize throughout the campaign, resulting in 30% efficiency in media spend.

Web3 Blockchain Infrastructure for Video, Media & Entertainment.

Quantum Cloud Future (Beijing) Technologies Co., Ltd., by leveraging future networking architecture and high-performance computing technologies, is able to bring together the world’s most advanced cloud computing, virtualization and Big Data technology to offer users across multiple industry verticals complete networking architecture, cloud computing, data center and Big Data system solutions. Quantum Cloud is committed to developing high-performance, scalable, deployable, secure and reliable multifaceted cloud service products. Headquartered in Beijing, China, the company now has branch offices across central and southern China as well as Silicon Valley.

Capital O is founded by 90s-gen GP with decacorn exits and best-among-peers track record. Partners have successful AI practices and are backed by seasoned veteran. Anchor LPs include Nasdaq CEOs, hedgefunds, and prestige family offices. Fund will be exploring frontier technologies including Autonomous Driving and AI Pharma, with strong anchor deals providing solid return profile. The Tech Era has started, we need to stay on the right side of change.

北京星亢原生物科技有限公司（neoX Biotech）是一家将人工智能（AI）与生物物理相结合，进行药物研发的生物高科技公司。星亢原专注大分子和多特异性分子药物研发，尤其是在肿瘤免疫治疗领域。 针对治疗药物的早期发现，星亢原通过表征蛋白质-蛋白质相互作用（PPI）开发了一个强大的研发平台。星亢原已经与国内外生物医药公司建立合作，布局药物研发管线。 星亢原由美国麻省理工学院和加州理工学院毕业的两位博士创立，核心研发团队来自北京大学、美国莱斯大学、中国科学院、德国亥姆霍兹感染研究中心、默沙东（MSD）等生物医药领域研究机构和跨国药企，团队成员曾在《自然》《科学》《细胞》等国际顶级期刊发表有重大影响力的学术文章，并被媒体报道。公司已经获得了包括红杉资本、五源资本（原晨兴资本）、元璟资本、真格基金、云九资本、祥峰投资、BAI资本在内的顶尖风险投资基金投资。

As the leading AI-based microbiome drug development company in China, Xbiome Co., Ltd. is dedicated to gut microbiome using AI techniques, and committed to the gut health of human being with medical treatments and precise and personalized management. The gut is the largest microbial ecosystem in the human body. It hosts about 100 trillion microbes – 500 – 1000 unique species, and contains 150-fold more genes than the human genome, which influence the human health systematically. Studies show that more than 50 human diseases are associated with dysbiosis of gut microbiota. Unlike the traditional paradigm of drug discovery, Xbiomes approach innovatively combines microbial technologies, artificial intelligence, bioinformatics analysis and gut microbiome technologies into a unique drug development platform, which substantially speeds up and improves the success rate of new drug development.

Sky9 Capital is a leading venture capital fund dedicated to supporting disruptive technologies and outstanding innovators to drive change and create positive impact for society, the environment and individual lives. Sky9 Capital team includes senior experts, entrepreneurs, and experienced investors from diverse backgrounds. Since 2011, the team has managed a number of USD and RMB funds, whose total assets under management of nearly USD 2 billion.

TuSimple is a global autonomous driving technology company headquartered in San Diego, California, with operations in the United States and Asia. Founded in 2015, TuSimple is developing commercial-ready, SAE Level 2+ through Level 4 autonomous driving solutions for long-haul heavy-duty trucks. TuSimple aims to transform the $4 trillion global truck freight industry through the companys leading AI technology, which makes it possible for trucks to drive safely autonomously, operate nearly continuously, and reduce fuel consumption by 10%+ relative to manually driven trucks. Global achievements include the worlds first fully autonomous, driver-out semi-truck run on open public roads, and development of the worlds first Autonomous Freight Network (AFN). We’re looking for creative and entrepreneurial individuals to join us. Please view positions at https://www.tusimple.com/careers/